SCHEMBL6202984

SCHEMBL6202984

COc1ccc(NCC(C)Cc2cnc(Cl)nc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
GAA P10253 5/20 0.42
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.35
KCNH3 Q9ULD8 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PPARG P37231 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692835 0.84 MAPT (0.45) MAPTGAAALDH1A1MEN1MAPK1
SCHEMBL6205531 0.82 MAPT (0.50) MAPTGAAALDH1A1SMN1; SMN2CYP1A2
SCHEMBL6204478 0.80 MAPT (0.47) MAPTGAAALDH1A1SMN1; SMN2CYP1A2
SCHEMBL4764898 0.74 ESR1 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL6207367 0.74 LMNA (0.47) MAPTGAAMEN1HTTKMT2A
SCHEMBL4689678 0.73 MEN1 (0.52) MAPTGAAALDH1A1MEN1HPGD
SCHEMBL4764854 0.72 CCKAR (0.45) CYP1A2
SCHEMBL6206031 0.71 PDXK (0.33)
SCHEMBL6204439 0.71
SCHEMBL4705013 0.71 MAPT (0.42) MAPTGAAALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed